Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V

Blood

Volumn 90, Issue 3, 1997, Pages 1065-1074

  Samis, John A ^a   Garrett, Marilyn ^a   Manuel, Reginald P ^a   Nesheim, Michael E ^a   Giles, Alan R ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; LEUKOCYTE ELASTASE; THROMBIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; HEMOSTASIS; HUMAN; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL;

EID: 0030787645     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1065     Document Type: Article

References (51)

1. Giles AR, Mann KG, Nesheim ME: A combination of factor Xa and phosphatidylcholine/phosphatidylserine vesicles bypasses factor VIII in vivo. Br J Haematol 69:491, 1988
2. Giles AR, Nesheim ME, Herring SW, Hoogendoorn H, Stump DC, Heldebrant CM: The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemost 63:476, 1990
3. Hoogendoorn H, Nesheim ME, Giles AR: A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model. Blood 75:2164, 1990
4. Giles AR, Nesheim ME, Mann KG: Studies of factors V and VIII:C in an animal model of disseminated intravascular coagulation. J Clin Invest 74:2219, 1984
5. Taylor Jr FB, Hoogendoorn H, Chang ACK, Peer G, Nesheim ME, Catlett R, Stump DC, Giles AR: Anticoagulant and fibrinolytic activities are promoted not retarded in vivo following thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 79:1720, 1992
6. Lee CD, Mann KG: Activation/inactivation of human factor V by plasmin. Blood 73:185, 1989
7. Rick ME, Krizek DM: Platelets modulate the proteolysis of factor VIII:C protein by plasmin. Blood 67:1649, 1986
8. Hoogendoorn H, Weitz JI, Giles AR: Evidence for the generation of elastase activity in a primate model of disseminated intravascular coagulation (DIC). Thromb Haemost 69:1127, 1993 (abstr)
9. Werb Z, Banda MJ, Mckerrow JH, Sandhaus RA: Elastases and elastin degradation. J Invest Dermatol 79:154s, 1982 (suppl)
10. Watorek W, Farley D, Salvesen G, Travis J: Neutrophil elastase and cathepsin G: Structure, function and biological control. Adv Exp Med Biol 240:23, 1988
11. Campbell EJ, Senior RM, Welgus HG: Extracellular matrix injury during lung inflammation. Chest 92:161, 1987
12. Travis J, Salvesen GS: Human plasma proteinase inhibitors. Ann Rev Biochem 52:655, 1983
13. Sifers RN, Shen RF, Woo SLC: Genetic control of human alpha-1-antitrypsin. Mol Biol Med 6:127, 1989
14. Janusz M, Doherty NS: Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G. J Immunol 146:3922, 1991
15. Jordan RE, Kilpatrick J, Nelson RM: Heparin promotes the inactivation of antithrombin by neutrophil elastase. Science 237:777, 1987
16. Higuchi DA, Wun T-C, Likert KM, Broze GJ: The effect of leukocyte on tissue factor pathway inhibitor. Blood 79:1712, 1992
17. Eckle I, Seitz R, Egbring R, Kolb G, Havemann K: Protein C degradation in vitro by neutrophil elastase. Biol Chem Hoppe-Seyler 372:1007, 1991
18. Eckle I, Seitz R, Egbring R, Kolb G, Havemann K: Protein S degradation in vitro by neutrophil elastase. Scand J Clin Lab Invest 53:281, 1993
19. Sie P, Dupouy D, Dol F, Boneu B: Inactivation of heparin cofactor II by polymorphonuclear leukocytes. Thromb Res 47:657, 1987
20. Brower MS, Harpel PC: Proteolytic cleavage and inactivation of a alpha(2)-plasmin inhibitor and C1 inactivator by human polymorphonuclear and leukocyte elastase. J Biol Chem 257:9849, 1982
21. Bach-Gansmo ET, Halvorsen S, Godal HC, Skjonsberg OH: Impaired coagulation of fibrinogen due to digestion of the C-terminal end of the A(alpha)-chain by human neutrophil elastase. Thromb Res 73:61, 1994
22. Varadi K, Marossy K, Asboth G, Elodi P, Elodi S: Inactivation of human factor VIII by granulocyte proteases. Thromb Haemost 43:45, 1980
23. Takaki A, Enfield DL, Thompson AR: Cleavage and inactivation of human factor IX by granulocyte elastase. J Clin Invest 72:1706, 1983
24. Turkington PT: Degradation of human factor X by human polymorphonuclear leukocyte cathepsin G and elastase. Haemostasis 21:111, 1991
25. Klingmann HG, Egbring R, Holst F, Gramse M, Havemann K: Degradation of human plasma fibrin stabilizing factor XIII subunits by human granulocytic proteinases. Thromb Res 28:793, 1982
26. Oates AM, Salem HH: The regulation of human factor V by a neutrophil protease. Blood 70:832, 1987
27. Okajima K, Fujise R, Motosato Y, Ushijima M, Okabe H, Takatsuki K: Plasma levels of granulocyte elastase-alpha 1 protease inhibitor complex in patients with disseminated intravascular coagulation: Pathophysiologic implications. Am J Hematol 47:82, 1994
28. Katzmann JA, Nesheim ME, Hibbard LS, Mann KG: Isolation of functional human coagulation Factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 78:162, 1981
29. Nesheim ME, Mann KG: Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem 254:1326, 1979
30. Bajaj SP, Rapaport SI, Maki SL, Brown SF: A procedure for the isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin. Prep Biochem 13:191, 1983
31. Lundblad RL, Kingdon HS, Mann KG: Thrombin, in Lorand L (ed): Methods in Enzymology. New York, NY, Academic, 1976, p 156
32. Fujikawa K, Legaz ME, Davie EW: Bovine factor X (Stuart Factor). Mechanism of activation by a protein from Russell's viper venom. Biochemistry 11:4892, 1972
33. Barenholz Y, Gibbs D, Litman BJ, Goll J, Thompson D, Carlson FD: A simple method for the preparation of homogeneous phospholipid vesicles. Biochem J 16:2806, 1977
34. Nesheim ME, Prendergast FG, Mann KG: Interactions of a fluorescent active-site-directed inhibitor of thrombin: Dansylarginine N-(3-Ethyl-1,5-pentanediyl)amide. Biochemistry 18:996, 1979
35. Neville DM: Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem 246:6328, 1971
36. Matsudaira P: Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 262:10035, 1987
37. Nesheim ME, Taswell JB, Mann KG: The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 254:10952, 1979
38. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG: Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846, 1987
39. Kane WH, Davie EW: Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539, 1988
40. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ: Cell surface-bound elastase and cathepsin G on human neutrophils: A novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 131:775, 1995
41. Nagamatsu Y, Yamamoto J, Fukuda A, Ohta M, Tsuda Y, Okada Y: Determination of leukocyte elastase concentration in plasma and serum by a simple method using a specific synthetic substrate. Haemostasis 21:338, 1991
42. Suzuki K, Dahlback B, Stenflo J: Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 257:6556, 1982
43. Kane WH, Majerus PW: Purification and characterization of human coagulation factor V. J Biol Chem 256:1002, 1981
44. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869, 1994
45. Allen DH, Tracy PB: Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J Biol Chem 270:1408, 1995
46. Geelen S, Bhattacharyya C, Tuomanen E: Induction of procoagulant activity on human endothelial cells by streptococcus pneumoniae. Infect Immun 60:4179, 1992
47. Carson SD, Johnson DR, Tracy SM: Tissue factor and the extrinsic pathway of coagulation during infection and vascular inflammation. Eur Heart J 14:98, 1993
48. Weitz JI, Silverman EK, Thong B, Campbell EJ: Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. J Clin Invest 89:766, 1992
49. Burnett D, Afford SC, Campbell EJ, Rios-Mollineda RA, Buttle DJ, Stockley RA: Evidence for lipid-associated serine proteases and metalloproteases in human bronchoalveolar lavage fluid. Clin Sci 75:601, 1988
50. Padrines M, Bieth JG: Elastin decreases the efficiency of neutrophil elastase inhibitors. Am J Respir Cell Mol Biol 4:187, 1991
51. Kane WH, Davie EW: Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci USA 83:6800, 1986